blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2518039

EP2518039 - Method for the preparation of therapeutically valuable triphenylbutene derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.07.2015
Database last updated on 24.04.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Forendo Pharma Ltd.
Itäinen Pitkäkatu 4B
20520 Turku / FI
[2014/47]
Former [2014/35]For all designated states
Hormos Medical Ltd.
Itäinen Pitkäkatu 4 B
20520 Turku / FI
Former [2012/44]For all designated states
Hormos Medical Ltd.
Itäinen Pitkäkatu 4 B
20520 Turku / FI
Inventor(s)01 / Södervall, Marja
Annantie 9 C 7
90560 Oulu / FI
02 / Eloranta, Maire
Mäntyrinne 18
90240 Oulu / FI
03 / Kalapudas, Arja
Notkolantie 13
90240 Oulu / FI
 [2012/44]
Representative(s)Kolster Oy Ab
(Salmisaarenaukio 1)
P.O. Box 204
00181 Helsinki / FI
[N/P]
Former [2014/35]Kolster Oy Ab
Iso Roobertinkatu 23
PO Box 148
00121 Helsinki / FI
Former [2013/20]Kolster Oy Ab
P.O. Box 148
00121 Helsinki / FI
Former [2012/44]Syvänen, Ralf Ossian
Kolster OY AB
Iso Roobertinkatu 23
P.O. Box 148
00121 Helsinki / FI
Application number, filing date12173502.113.02.2008
[2012/44]
Priority number, dateUS20070889838P14.02.2007         Original published format: US 889838 P
[2012/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2518039
Date:31.10.2012
Language:EN
[2012/44]
Type: A9 Corrected patent application 
No.:EP2518039
Date:13.02.2013
[2013/07]
Type: B1 Patent specification 
No.:EP2518039
Date:27.08.2014
Language:EN
[2014/35]
Type: B8 Corrected title page of specification 
No.:EP2518039
Date:17.12.2014
[2014/51]
Search report(s)(Supplementary) European search report - dispatched on:EP01.10.2012
ClassificationIPC:C07C41/01, C07C41/16, C07C41/26, C07C41/30, C07C43/225, C07C43/23, C07C67/31
[2012/44]
CPC:
C07C41/30 (EP,US); C07C43/23 (KR); A61P19/10 (EP);
A61P3/06 (EP); A61P35/00 (EP); C07C41/01 (KR);
C07C41/26 (EP,US); C07C67/31 (EP,US); Y02P20/55 (EP,US) (-)
C-Set:
C07C41/26, C07C43/23 (US,EP);
C07C41/30, C07C43/23 (US,EP);
C07C67/31, C07C69/712 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/44]
TitleGerman:Verfahren zur Herstellung von therapeutisch nützlichen Triphenylbutenderivaten[2012/44]
English:Method for the preparation of therapeutically valuable triphenylbutene derivatives[2012/44]
French:Procédé de préparation de dérivés de triphénylbuténe d'une valeur thérapeutique[2012/44]
Examination procedure24.04.2013Amendment by applicant (claims and/or description)
24.04.2013Examination requested  [2013/23]
24.06.2013Despatch of a communication from the examining division (Time limit: M04)
24.10.2013Reply to a communication from the examining division
14.03.2014Communication of intention to grant the patent
09.07.2014Fee for grant paid
09.07.2014Fee for publishing/printing paid
09.07.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08718510.4  / EP2121553
Divisional application(s)EP14178678.0  / EP2821385
Opposition(s)28.05.2015No opposition filed within time limit [2015/32]
Fees paidRenewal fee
26.06.2012Renewal fee patent year 03
26.06.2012Renewal fee patent year 04
26.06.2012Renewal fee patent year 05
15.02.2013Renewal fee patent year 06
21.02.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.08.2014
BE27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
MC27.08.2014
MT27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
TR27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
LU13.02.2015
CH28.02.2015
LI28.02.2015
[2017/46]
Former [2017/03]AT27.08.2014
BE27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
MC27.08.2014
MT27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
LU13.02.2015
CH28.02.2015
LI28.02.2015
Former [2016/32]AT27.08.2014
BE27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
MC27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
LU13.02.2015
CH28.02.2015
LI28.02.2015
Former [2015/47]AT27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
MC27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
LU13.02.2015
BE28.02.2015
CH28.02.2015
LI28.02.2015
Former [2015/46]AT27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
MC27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
LU13.02.2015
BE28.02.2015
Former [2015/44]AT27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
LU13.02.2015
BE28.02.2015
Former [2015/30]AT27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
BE28.02.2015
Former [2015/24]AT27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
PL27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
Former [2015/23]AT27.08.2014
CY27.08.2014
CZ27.08.2014
DK27.08.2014
EE27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
RO27.08.2014
SK27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
Former [2015/22]AT27.08.2014
CY27.08.2014
DK27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
RO27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
Former [2015/12]AT27.08.2014
CY27.08.2014
FI27.08.2014
LT27.08.2014
LV27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
IS27.12.2014
PT29.12.2014
Former [2015/11]CY27.08.2014
FI27.08.2014
LT27.08.2014
BG27.11.2014
NO27.11.2014
GR28.11.2014
PT29.12.2014
Former [2015/10]FI27.08.2014
LT27.08.2014
BG27.11.2014
NO27.11.2014
Former [2015/09]FI27.08.2014
LT27.08.2014
Former [2015/08]LT27.08.2014
Documents cited:Search[ID]WO0136360  (HORMOS MEDICAL OY LTD [FI], et al) [ID] 1-13 * page 51, line 3 - line 8 * * page 49, line 6 - line 11 * * page 46, line 4 - line 10 *
by applicantWO9607402
 WO9732574
 WO0207718
 WO03103649
 WO0136360
 WO2004108645
 WO2006024689
 WO02090305
 EP0095875
 US6891070
    - KAUFFMAN; BRYANT, DRUG NEWS PERSPECT., (1995), vol. 8, pages 531 - 539
    - KANGAS, CANCER CHEMOTHER. PHARMA- COL., (1990), vol. 27, pages 8 - 12
    - T.W. GREENE; P.G.M. WUTS, Protecting Groups in Organic Synthesis, WILEY INTERSCIENCE, (1999), pages 23 - 200
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.